These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5590094)

  • 21. [Further data on the association of bacteriophage with antibiotic therapy for the purpose of sterilizing carriers of dysentery bacilli].
    Zilişteanu C; Mintzer-Morgenstern L; Ionesco H; Ionesco-Dorohoi T
    Arch Roum Pathol Exp Microbiol; 1969 Dec; 28(4):1073-80. PubMed ID: 5398933
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on combined chloramphenicol streptomycin therapy.
    Ghosh S; Mukherjee BP; Mitra D
    J Indian Med Assoc; 1984 Nov; 82(11):402-4. PubMed ID: 6535799
    [No Abstract]   [Full Text] [Related]  

  • 23. [Method of treatment of patients with dysenteric colitis].
    Moshchich PS; Dishuk II
    Vrach Delo; 1973 Oct; 10():146-8. PubMed ID: 4783284
    [No Abstract]   [Full Text] [Related]  

  • 24. [Shigella flexneri diarrhoea with positive blood culture].
    Taieb B; Ghnassia JC; Berche P; Hennequet A
    Ann Pediatr (Paris); 1978; 25(5-6):266-8. PubMed ID: 16114334
    [No Abstract]   [Full Text] [Related]  

  • 25. [Considerations on tetracycline therapy of acute bacillary dysentery].
    Băliban A; Simu V; Văleanu L
    Microbiol Parazitol Epidemiol (Bucur); 1968; 13(4):325-7. PubMed ID: 5700956
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of bacillary dysentery].
    Gioieni A
    Clin Ter; 1980 Jan; 92(2):197-80. PubMed ID: 7389276
    [No Abstract]   [Full Text] [Related]  

  • 27. [Efficacy of antibacterial therapy in patients with various forms of dysentery].
    Pokrovskiĭ VI; Tumanov FA; Iushchik ND; Mashilov VP; Shalygina NB
    Klin Med (Mosk); 1976 Apr; 54(4):133-6. PubMed ID: 1037009
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of dysenteric polyvalent bacteriophage in coated tablets for treatment of acute dysentery].
    Nasonova AS; Chizhov EA
    Sov Med; 1970 Jul; 33(7):143-4. PubMed ID: 4321394
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antibiotic therapy in 1971].
    Helwig H
    Med Monatsschr; 1971 May; 25(5):222-7. PubMed ID: 4931430
    [No Abstract]   [Full Text] [Related]  

  • 30. [Indices of ceruloplasmin activity and copper and zinc blood levels in patients with abdominal typhus and dysentery during treatment with levomycetin].
    Borisova MA
    Sov Med; 1966 Jan; 29(1):59-63. PubMed ID: 5985166
    [No Abstract]   [Full Text] [Related]  

  • 31. [Behavior of total proteins, of protein fractions and of serum electrolytes in patients with acute bacillary dysentery].
    KEDROWA S; POZNANSKA H
    Przegl Epidemiol; 1960; 14():355-60. PubMed ID: 13752132
    [No Abstract]   [Full Text] [Related]  

  • 32. Changing needs in the antimicrobial therapy of shigellosis.
    Weissman JP; Gangarosa EJ; Dupont HL
    J Infect Dis; 1973 May; 127(5):611-3. PubMed ID: 4489825
    [No Abstract]   [Full Text] [Related]  

  • 33. [Rational antibiotic therapy of intestinal infections].
    Grishchenko RI; Sakal' NN; Kishko AM; Turianina SM
    Vrach Delo; 1980 Mar; (3):115-8. PubMed ID: 6990622
    [No Abstract]   [Full Text] [Related]  

  • 34. [The mechanisms of action of probiotics on lymphocyte function in acute shigellosis].
    Isaeva NP; Shakhmardanov MZ; Zemskova LN; Grigor'ev AV; Luchshev VI
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):107-8. PubMed ID: 7879496
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug resistance of Shigella species: changes over 20 years in Turkey.
    Ergönül O; Imre A; Celikbaş A; Dokuzoğuz B
    Int J Antimicrob Agents; 2004 May; 23(5):527-8. PubMed ID: 15120738
    [No Abstract]   [Full Text] [Related]  

  • 36. Furazolidone in the treatment of institutional shigellosis.
    Fish CH; Jones G
    Am J Ment Defic; 1968 Sep; 73(2):214-7. PubMed ID: 5696170
    [No Abstract]   [Full Text] [Related]  

  • 37. ["Usual" antibiotics in the treatment of current bacillary dysentery].
    Slivinschi R; Dracinschi W; Mocanu A
    Microbiol Parazitol Epidemiol (Bucur); 1973; 18(2):155-7. PubMed ID: 4717230
    [No Abstract]   [Full Text] [Related]  

  • 38. Transcobalamin II level in peripheral blood monocytes--a biochemical marker in inflammatory diseases of the bowel.
    Rachmilewitz D; Ligumsky M; Rachmilewitz B; Rachmilewitz M; Tarcic N; Schlesinger M
    Gastroenterology; 1980 Jan; 78(1):43-6. PubMed ID: 7350034
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy of bacillary dysentery with various antibiotics--with special reference to Lincomycin therapy].
    Tajimi H; Takeyama Y; Imagawa Y
    Nihon Densenbyo Gakkai Zasshi; 1967 Sep; 41(6):212-8. PubMed ID: 4966966
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical and treatment characteristics of acute dysentery caused by Shigella boydii and newcastle].
    Mel'nik GV
    Vrach Delo; 1984 Aug; (8):114-7. PubMed ID: 6390958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.